Skip to main content

Table 3 Distribution of CRS by intratumoral and stromal CD8 + TILs

From: The predictive role of PD-L1 expression and CD8 + TIL levels in determining the neoadjuvant chemotherapy response in advanced ovarian cancer

Intraepithelial CD8 + TILs

 

CRS 1

N, (%)

CRS 2

N, (%)

CRS 3

N, (%)

Total

N

p

 

Low expression

6 (24.0%)

13 (52.0%)

6 (24.0%)

25

0.303

 

High Expression

2(10.0%)

15(75.0%)

3 (15.0%)

20

 

Stromal CD8 + TILs

      
 

Low expression

3(30.0%)

6(60.0%)

1(10.0%)

10

0.396

 

High Expression

5(14.3%)

22(62.9%)

8(22.9%)

35